Precision Oncology Showcase

The Precision Oncology Showcase is an engaging online event that explores the latest advancements in precision oncology technologies. This showcase will delve into critical topics such as genomic profiling, immuno-oncology biomarkers, circulating tumor cell (CTC) analysis, and innovative liquid biopsy methods. Attendees will gain insights into how leaders in pharmaceuticals and biotechnology are utilizing these transformative tools to personalize cancer treatments and improve clinical decision-making processes.Participants will have the opportunity to position their technologies directly in front of key decision-makers from the pharmaceutical, biotech, and academic sectors who are actively involved in oncology biomarkers, clinical genomics, and translational oncology. The event will feature prominent industry speakers, including Peter Sondermann, Gilles Erb, Dana Mustafa, Ásta Rós Sigtryggsdóttir, and Steve Hood, who will present alongside exhibitors to showcase how their solutions are being effectively applied in real-world scenarios. The showcase aims to align brands with innovation in precision oncology, allowing companies to gain visibility as thought leaders while engaging in meaningful discussions on genomic profiling, liquid biopsy tools, immuno-oncology biomarkers, and personalized treatment strategies. Attendees can expect to engage directly with senior stakeholders through live Q&A sessions and interactive segments, fostering valuable connections with potential customers and collaborators. This event is not only an opportunity to witness the latest tools in action but also to understand their real-world impact and leave with practical takeaways to apply in research and clinical settings. The Precision Oncology Showcase is designed to reach a broad audience across the USA, making it a significant platform for networking and knowledge exchange in the field of precision oncology.